BMO Capital analyst, George Farmer, reiterated a Market Perform rating on Biogen (NASDAQ: BIIB) on the belief that the failure ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE